Otsuka Holdings
4578.T
#637
Rank
โ‚น3.437 T
Marketcap
โ‚น6,510
Share price
-0.88%
Change (1 day)
50.15%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): โ‚น258.54

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น284.95. an increase over its 2024 EPS that were of โ‚น373.93.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025โ‚น405.708.5%
2024โ‚น373.93153.9%
2023โ‚น147.27-15.71%
2022โ‚น174.72-6.18%
2021โ‚น186.22-24.1%
2020โ‚น245.3622.95%
2019โ‚น199.5656.13%
2018โ‚น127.82-25.11%
2017โ‚น170.6825.99%
2016โ‚น135.48-6.37%
2015โ‚น144.70
2014N/A-100%
2013โ‚น218.0118.06%
2012โ‚น184.661.01%
2011โ‚น182.8029.07%
2010โ‚น141.63-94.47%
2009โ‚น2,561